Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
This dual incretin research peptide targets the same GLP-1R/GIPR receptor pathway and is used in preclinical laboratory models examining twincretin signaling mechanisms
Product range includes BPC-157, available as a standalone peptide or in a blended formulation: (1) M.J.Hsieh et al (2016) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation Journal of Molecular Medicine, 15 November 2016, Volume 95, pages 323333
A long-acting amylin analogue utilized in laboratory research to study peptide signaling pathways
[accessed 21 November 2023] Eli Lilly and Company 2021
US$ 23.82
US$ 29.09
US$ 25.41
US$ 20.69
US$ 26.20
US$ 27.54
